Skip to main content

Drug delivery has progressed over the last six decades until becoming an essential part of pharmaceutical sciences. From the first active delivery approved for clinical use, the technology has brought remarkable developments with significant clinical implications. In medicine, topical and transdermal route have been increasingly used as alternative to oral route in cosmetics, delivery system investigations are GROWING RAPIDLY.

Up to 25 parameters are considered by our researchers when developing an active delivery system.

Such as:
Size: Delivering small and large molecules.
Payload: Delivering large volumes of actives into the skin.
Depth: Delivering compounds deep into the skin
Targeting: Delivering actives to specific areas and, as well, skin target cells.
Speed: Delivering active ingredients into and through the skin within minutes, not hours.
Booster: Enhancing the penetration performance of existing delivery systems.
Concentration: Stabilizing large volumes (a “high load factor”) of actives in a finished formulation or minimizing the dosage for efficacy.
Bioavailability: Delivering actives over time enables principles to expand its activity and its effects on skin for longer periods of time, to avoid non-activity periods between applications and maximize cosmetic results with lower dosages.
Simplicity: Our delivery systems are usually formulated into a topical product by simply homogenizing (mixing) the ingredients.
Versatility: Delivery systems can be incorporated into almost any form factor.
Easy-customization: Delivery systems can easily be customized to match clients’ expectations on performance, efficacy or exclusivity.
Patented: Our main delivery systems are protected by a global portfolio of patents issued including pending applications.

Leave a Reply